05/18/2020 / By Ethan Huff
Our neighbors to the north have created a partnership with communist China to develop a new vaccine for the Wuhan coronavirus (COVID-19).
According to reports, Canada’s National Research Council (NRC) has agreed to work together with the regime that let loose the Wuhan coronavirus (COVID-19) in the first place to finish developing and begin testing Canada’s Ad5-nCoV vaccine candidate, which has been under joint development by a Chinese corporation and the nation’s military.
While numerous vaccine candidates for the Wuhan coronavirus (COVID-19) are currently under development around the world, Canada’s Ad5-nCoV vaccine is among the most rapidly developed, which could mean that it will come to market before any others.
The partnership involves Canada agreeing to support the development of this vaccine on its own soil by manufacturing doses that can be administered to humans as part of clinical trials, as well as be used for emergency pandemics.
“We are going to get to evaluate it for safety and efficacy in Canada, as is being done already in China, and Canada will now be part of the front-runner story,” stated Roman Szumski, vice president of life science for the NRC.
China has likewise confirmed the partnership, indicating that it is actively working with a number of countries to develop a new vaccine for the Wuhan coronavirus (COVID-19).
A Foreign Ministry spokesperson explained during a recent press briefing in Beijing that the Chinese corporation CanSino Biologics Inc. is working with Canada’s NRC to unveil a vaccine sooner rather than later. Once ready, CanSino will submit applications to Health Canada to begin clinical trials of the injection.
China also says that it “donated” 32 tons of medical supplies to Canada as part of the country’s “active assistance and convenience” measures supposedly aimed at making it easier for Canada to purchase the things it needs to battle the pandemic.
Because the Wuhan coronavirus (COVID-19) respects no borders, according to Chinese spokesperson Zhao Lijian, a vaccine is necessary to both fight the pandemic and prevent the continued spread of the novel virus.
The vaccine is already undergoing phases I and II of the clinical trial process in China. One completed, it will then move over to Canada for further testing and approval.
While this partnership is being lauded by the governments of both Canada and China as a positive step forward in the fight against the Wuhan coronavirus (COVID-19), many Canadian people are reportedly not on board with the deal, particularly because of the Huawei Technologies Co. scandal and China’s involvement in the global 5G rollout.
President Donald Trump, as many readers may know, basically kicked Huawei out of the U.S. and blacklisted the use of the company’s telecom chips here in America. Canada has not yet made a decision on the matter, though the country’s military reportedly warned Justin Trudeau about the threat of Huawei chips to Canadian security.
More than 100,000 Canadians have signed a petition calling on the Canadian government to ban Huawei from the country.
“Almost all of our allies have banned or removed Huawei from their critical infrastructure and it’s time we do the same!” the petition reads.
“In several publicly available news article FBI Director Christopher Wray, CIA Director Mike Pompeo, and Director of National Intelligence Dan Coats have all publicly stated several times that Huawei is using its technology to spy on companies with the objective of stealing its intellectual property. It is my opinion along with many others that Huawei is not an ethical player in the market place and therefore should be banned!”
To keep up with the latest news about the Wuhan coronavirus (COVID-19), be sure to check out Pandemic.news.
Sources for this article include:
Vaccines.News is a fact-based public education website published by Vaccines News Features, LLC.
All content copyright © 2018 by Vaccines News Features, LLC.
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.